NCT02587455 - Pembrolizumab and Palliative Radiotherapy in Lung | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 24, 2016

Primary Completion Date

August 20, 2021

Study Completion Date

August 20, 2021

Conditions

Thoracic Tumours

Interventions

DRUG

Pembrolizumab

Pembrolizumab - Trial Treatment

RADIATION

Radiotherapy

Radiotherapy - Standard Treatment

Trial Locations (2)

NIHR Biomedical Research Centre at RM and ICR (https://www.cancerbrc.org/), London

NIHR Biomedical Research Centre at RM and ICR (https://www.cancerbrc.org/), Sutton

All Listed Sponsors

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Institute of Cancer Research, United Kingdom

OTHER

collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

Royal Marsden NHS Foundation Trust

OTHER